Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 706 in advanced gastrointestinal stromal tumors
NCT00089960Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of motesanib in gastrointestinal stromal tumor (GIST), sponsored by Amgen. Started Oct 2004; status: completed.
02
Drugs
motesanib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00089960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089960.